Topic
BioNTech
5 facts from 5 episodes, in date order. These are what speakers said on the shows, each linked to the moment it was said. They aren't independently verified.
2020
Pfizer already had an agreement with BioNTech to develop mRNA technology, working on a flu vaccine, before they began their COVID-19 vaccine collaboration.
“we had already an agreement with BioNTech to work on this technology, and we were working with them on a flu vaccine.”
Albert Bourla · Ep. 112: Speed of Science, with Pfizer’s Albert Bourla and Johnson & Johnson’s Alex Gorsky, 0:05:25
2020
Host Luke Timmerman credits Pfizer with helping BioNTech develop an mRNA COVID-19 vaccine in record time with very high efficacy.
“And I really want to give hats off to Pfizer for stepping up and helping BioNTech and developing this mRNA vaccine in record time and incredible efficacy.”
Luke Timmerman · Ep95: Sue Desmond-Hellmann on Becoming a Biotech Leader, 0:03:05
2020
Moderna chose to market its COVID vaccine itself, while BioNTech went to market through Pfizer.
“Moderna made the decision to go to market by ourselves. BioNTech didn't have that luxury, was too small probably at the time, and went to market through Pfizer.”
Brice Challamel · #249 Brice Challamel: How Moderna is Using AI to Disrupt Modern Healthcare, 0:42:26
Undated
Bourla says Pfizer was already working with BioNTech to develop an mRNA flu vaccine before choosing mRNA for COVID.
“we were working with this company, with BioNTech, to develop a flu vaccine for the rest of the years.”
Albert Bourla · 38. Pfizer’s CEO on the Big Gamble That Brought Us the COVID Vaccine, 0:14:50
Undated
Dave Ricks said China held rights to the BioNTech-Pfizer COVID-19 vaccine through nearly the whole pandemic but never approved it.
“They had rights to the BioNTech Pfizer vaccine for almost the entirety of their pandemic. They never approved it.”
Dave Ricks · Dave Ricks, CEO of Eli Lilly, on GLP-1s and the business of pharma, 1:14:35